M
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Michela Palmieri's research investigates mechanisms of bone loss and potential therapeutic interventions, with a focus on the role of osteocytes and oxidized phospholipids in age-associated bone loss in mice. Her work also explores signaling axes in multiple myeloma that contribute to chemoresistance and examines autophagic imbalances in Mecp2-deficient models relevant to neurological disorders.
Palmieri has published on advanced genetic therapies for Rett syndrome and has investigated the contribution of senescent osteocytes to bone destruction in breast cancer metastasis. Her scholarship metrics include an h-index of 35, with over 10,686 citations across 84 publications. She is recognized as a highly cited researcher and maintains an active research group at the University of Arkansas for Medical Sciences, collaborating with Elena Ambrogini, Teenamol E. Joseph, Charles A. O’Brien, and Horacio Gómez-Acevedo.
Metrics
- h-index: 35
- Publications: 83
- Citations: 10,835
Selected Publications
-
Deletion of the scavenger receptor Scarb1 in osteoblast progenitors and myeloid cells does not affect bone mass (2025)
-
Deletion of the scavenger receptor <i>Scarb1</i> in osteoblast progenitors and myeloid cells does not affect bone mass (2025)
-
Plasma levels of anti phosphocholine IgM antibodies are negatively correlated with bone mineral density in humans (2025)
-
Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer (2024)
-
Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer Metastasis (2024)
-
A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma (2024)
-
OR27-02 The Bone Anabolic Effect Of An Antibody Blocking Oxidized Phospholipids Is Associated With An Increase In Wnt10b In Osteoblasts. (2023)
-
Retraction notice to “Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass” [Bone 170(2023) 116702] (2023)
-
Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation (2023)
-
RETRACTED: Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass (2023)
-
Deletion of the Scavenger Receptor Scarb1 in Myeloid Cells Does Not Affect Bone Mass (2022)
-
Deletion of the scavenger receptor Scarb1 in osteoblast progenitors does not affect bone mass (2022)
-
Neutralization of oxidized phospholipids attenuates age‐associated bone loss in mice (2021)
Collaboration Network
Top Collaborators
Elena Ambrogini
University of Arkansas for Medical Sciences
17 shared publications
In database
- Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation
- Neutralization of oxidized phospholipids attenuates age‐associated bone loss in mice
- A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma
- Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer Metastasis
- Deletion of the scavenger receptor Scarb1 in osteoblast progenitors does not affect bone mass
Showing 5 of 17 shared publications
Charles A. O’Brien
Central Arkansas Veterans Healthcare System
12 shared publications
In database
- Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation
- Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer Metastasis
- Deletion of the scavenger receptor Scarb1 in osteoblast progenitors does not affect bone mass
- RETRACTED: Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass
- Retraction: Deletion of the scavenger receptor Scarb1 in osteoblast progenitors does not affect bone mass
Showing 5 of 12 shared publications
Teenamol E. Joseph
Central Arkansas Veterans Healthcare System
11 shared publications
In database
- Neutralization of oxidized phospholipids attenuates age‐associated bone loss in mice
- Deletion of the scavenger receptor Scarb1 in osteoblast progenitors does not affect bone mass
- RETRACTED: Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass
- Retraction: Deletion of the scavenger receptor Scarb1 in osteoblast progenitors does not affect bone mass
- Blocking Oxidized Phospholipids Attenuates the Age-Associated, but Not the Ovariectomy- or Unloading- Induced, Bone Loss in Mice
Showing 5 of 11 shared publications
Horacio Gómez-Acevedo
University of Arkansas for Medical Sciences
10 shared publications
In database
- Neutralization of oxidized phospholipids attenuates age‐associated bone loss in mice
- Deletion of the scavenger receptor Scarb1 in osteoblast progenitors does not affect bone mass
- RETRACTED: Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass
- Retraction: Deletion of the scavenger receptor Scarb1 in osteoblast progenitors does not affect bone mass
- Blocking Oxidized Phospholipids Attenuates the Age-Associated, but Not the Ovariectomy- or Unloading- Induced, Bone Loss in Mice
Showing 5 of 10 shared publications
Stavros C. Manolagas
University of Arkansas for Medical Sciences
9 shared publications
In database
- Neutralization of oxidized phospholipids attenuates age‐associated bone loss in mice
- Deletion of the scavenger receptor Scarb1 in osteoblast progenitors does not affect bone mass
- RETRACTED: Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass
- Retraction: Deletion of the scavenger receptor Scarb1 in osteoblast progenitors does not affect bone mass
- Blocking Oxidized Phospholipids Attenuates the Age-Associated, but Not the Ovariectomy- or Unloading- Induced, Bone Loss in Mice
Showing 5 of 9 shared publications
Intawat Nookaew
7 shared publications
In database
- Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation
- Neutralization of oxidized phospholipids attenuates age‐associated bone loss in mice
- A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma
- Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer Metastasis
- OR27-02 The Bone Anabolic Effect Of An Antibody Blocking Oxidized Phospholipids Is Associated With An Increase In Wnt10b In Osteoblasts.
Showing 5 of 7 shared publications
Ha‐Neui Kim
University of Arkansas for Medical Sciences
6 shared publications
In database
- RETRACTED: Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass
- Deletion of the Scavenger Receptor Scarb1 in Myeloid Cells Does Not Affect Bone Mass
- Retraction notice to “Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass” [Bone 170(2023) 116702]
- OR27-02 The Bone Anabolic Effect Of An Antibody Blocking Oxidized Phospholipids Is Associated With An Increase In Wnt10b In Osteoblasts.
- Deletion of the scavenger receptor <i>Scarb1</i> in osteoblast progenitors and myeloid cells does not affect bone mass
Showing 5 of 6 shared publications
Maria Almeida
4 shared publications
In database
- Neutralization of oxidized phospholipids attenuates age‐associated bone loss in mice
- Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer Metastasis
- Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer
- 12538 Blocking Oxidized Phospholipids Improves Bone Mass In Mice By Transcriptional Reprogramming Of Osteoblastic Cells: Analysis At The Single Cell Level
Jeff D. Thostenson
3 shared publications
In database
- Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation
- Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption
- Plasma levels of anti phosphocholine IgM antibodies are negatively correlated with bone mineral density in humans
C. Lowry Barnes
University of Arkansas for Medical Sciences
3 shared publications
In database
- Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation
- A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma
- Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer Metastasis
Jeffrey B. Stambough
University of Arkansas for Medical Sciences
3 shared publications
In database
- Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation
- Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer Metastasis
- Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer
Hayley M. Sabol
University of Arkansas for Medical Sciences
3 shared publications
In database
- A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma
- Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer Metastasis
- Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer
Manish Adhikari
University of Arkansas for Medical Sciences (US)
3 shared publications
- A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma
- Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer Metastasis
- Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer
Aric Anloague
University of Arkansas for Medical Sciences
3 shared publications
In database
- A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma
- Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer Metastasis
- Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer
Japneet Kaur
University of Arkansas for Medical Sciences
3 shared publications
In database
- A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma
- Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer Metastasis
- Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer
Similar Researchers
Based on overlapping research topics
Murat M.D. Gokden
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Cancer-related molecular mechanisms research
Neurological disorders and treatments
John Gillenwater
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Cancer-related molecular mechanisms research
Animal Behavior and Welfare Studies
Julie A. Wallace
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Cancer-related molecular mechanisms research
Animal Behavior and Welfare Studies
Emily E. Rothacker
University of Arkansas at Fayetteville
Metabolism and Genetic Disorders
Neurological disorders and treatments
Animal Behavior and Welfare Studies
Jonathan D. Hoang
University of Arkansas at Fayetteville
Metabolism and Genetic Disorders
Neurological disorders and treatments
Animal Behavior and Welfare Studies
Alexandra Gutierrez Vega
University of Arkansas at Fayetteville
Bone Metabolism and Diseases
Cancer-related molecular mechanisms research
Disease Mechanisms Research